par Chalhoub, Houssein
;Daubie, Valéry
;Dahma, Hafid
;Blasdel, Bob B.G.;Tytgat, Isabelle
;Quintens, Johan;Vandenberg, Olivier
;Hallin, Marie 
Référence Microbiology spectrum, 14, 10, page (e0078226)
Publication Publié, 2026-10-01
;Daubie, Valéry
;Dahma, Hafid
;Blasdel, Bob B.G.;Tytgat, Isabelle
;Quintens, Johan;Vandenberg, Olivier
;Hallin, Marie 
Référence Microbiology spectrum, 14, 10, page (e0078226)
Publication Publié, 2026-10-01
Article révisé par les pairs
| Résumé : | Antimicrobial resistance is a major threat to human health. Phage therapy is a promising alternative to antibiotics, yet routine diagnostic tools capable of rapidly determining phage susceptibility are lacking. Our goal was to develop a diagnostic tool providing easy-to-interpret in vitro phage activity results within a clinically relevant time frame. We developed a prototype based on bioluminescence emitted by adenosine triphosphate (ATP) release during phage-mediated bacterial lysis. Ten phages were tested against 20 clinical isolates of four species: Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli, and Klebsiella pneumoniae. Overall concordance with double agar overlay (DAO) was fair (72%). The prototype showed high sensitivity (94.5%) at detecting weak killers and high specificity (87%) at identifying strong killer phages. Most discordances involved DAO weak killers classified as active by the prototype. Most of these discordant phage-bacteria couples produced a spot in the spot test, suggesting the assay may detect but not distinguish killing without replication from killing with replication. The method showed high repeatability and reproducibility. A few aberrant species specificity results highlighted the need for routine controls. Results from prospective urine samples were obtained within an average of 5 h. |



